AV5080
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for AV5080, covering 2021-10-26 to 2021-10-27. Get the full timeline:
Most recent: Clinical Trial Update: Dose Range Study to Evaluate the Efficacy and Safety of AV5080 in Patients With Influenza [Phase 2]